By stimulating breast cancer cells with growth factors released by endothelial cells, such as EGF or TGFβ, we found that EGF, but not TGFβ, can lead to breast cancer cell elongation compatible with extravasation. The gene discussed is EGF; the disease is breast carcinoma.